Spyre Therapeutics Plunges; Why Analysts Aren't Sweating
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Expedia Executive Sells 3,133 Shares for $1 Million
An Expedia insider disposed of more than 3,000 shares after a strong 12-month run for the stock price.
Will Bloom Energy Be the Next SpaceX? What the Numbers Actually Say.
Key PointsBloom Energy’s stock skyrocketed over the past two years.
AMD vs. Marvell: Which Is the Better AI Chip Stock to Own for the Next 5 Years?
AMD and Marvell have both performed well over the past year.
1 Wall Street Analyst Just Upgraded AMD Stock and Estimates 30% Upside. Here's Why He's Bullish on This Semiconductor Stock.
AMD is riding the next wave of AI chip demand.
